title: EMPA-REG - the "diuretic hypothesis".
authors.affiliation: Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, Scotland. Electronic address: John.McMurray@glasgow.ac.uk.
authors.forename: John
authors.initials: J
authors.lastname: McMurray
mesh_terms: D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000150:complications / Q000453:epidemiology / Q000517:prevention & control / Q000628:therapy; D001559:Benzhydryl Compounds / Q000627:therapeutic use*; D018849:Controlled Clinical Trials as Topic; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism; D058065:Diabetic Cardiomyopathies / Q000453:epidemiology / Q000517:prevention & control* / Q000628:therapy; D004232:Diuretics / Q000627:therapeutic use*; D005960:Glucosides / Q000627:therapeutic use*; D006333:Heart Failure / Q000150:complications / Q000453:epidemiology / Q000517:prevention & control* / Q000628:therapy; D006760:Hospitalization; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D049990:Membrane Transport Modulators / Q000627:therapeutic use; D008954:Models, Biological; D012306:Risk; D051297:Sodium-Glucose Transporter 2 / Q000378:metabolism; D000077203:Sodium-Glucose Transporter 2 Inhibitors
chemical_list: D000889:Anti-Arrhythmia Agents; D001559:Benzhydryl Compounds; D004232:Diuretics; D005960:Glucosides; D007004:Hypoglycemic Agents; D049990:Membrane Transport Modulators; C089180:SLC5A2 protein, human; D051297:Sodium-Glucose Transporter 2; D000077203:Sodium-Glucose Transporter 2 Inhibitors; C570240:empagliflozin